Regenesome Inc. ” Raises 80 Million Yen in Pre-Seed Round
Regenesome Inc.
- Industry
- Pharmaceutical
- Area
- Tokyo
- Unlisted
Regenesome Inc.
By carrying out omics-related analyses in cultured cells in different environments and in human clinical trials, as well as by analysing exosomes in detail, we will clarify how each environment is involved in the production of exosomes and how exosomes function in the organism.
Daiya building 2F 2-2-15 Hamamatsucho, Minato-ku
Corporate Data
| Company name | Regenesome Inc. |
|---|---|
| Representative | Zentaro Sakuma |
| Founded | July 12, 2024 |
| Established | July 12, 2024 |
| Capital | ¥5,000,000 |
| Number of employees |
Non-consolidated 2 Consolidated 2 |
| URL |